These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2587618

  • 1. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A, Bucci FA, Del Val M, Cruz E.
    Pharmacology; 1989; 39(1):59-68. PubMed ID: 2587618
    [Abstract] [Full Text] [Related]

  • 2. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A, Diecke FP, Mistry K, Ellison C, Cruz E.
    Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 4. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A, Mistry K, Diecke FP, Cruz E.
    Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
    [Abstract] [Full Text] [Related]

  • 5. Myo-inositol transport in the lens of galactose-maintained rats.
    Beyer-Mears A, Diecke FP, Cruz E, Mistry K.
    Curr Eye Res; 1992 Jan; 11(1):25-34. PubMed ID: 1559389
    [Abstract] [Full Text] [Related]

  • 6. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A, Kelly K, Cruz E.
    Pharmacology; 1985 Jan; 31(3):170-9. PubMed ID: 3931105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E, Varagiannis E.
    Pharmacology; 1985 Jan; 31(2):88-96. PubMed ID: 3927328
    [Abstract] [Full Text] [Related]

  • 9. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 10. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
    [Abstract] [Full Text] [Related]

  • 11. Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats.
    Abdul Nasir NA, Agarwal R, Sheikh Abdul Kadir SH, Vasudevan S, Tripathy M, Iezhitsa I, Mohammad Daher A, Ibrahim MI, Mohd Ismail N.
    PLoS One; 2017 Sep; 12(3):e0174542. PubMed ID: 28350848
    [Abstract] [Full Text] [Related]

  • 12. Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol.
    Mackic JB, Ross-Cisneros FN, McComb JG, Bekhor I, Weiss MH, Kannan R, Zlokovic BV.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):804-10. PubMed ID: 8125742
    [Abstract] [Full Text] [Related]

  • 13. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S, Kikuchi C, Ono T, Notsu Y.
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [Abstract] [Full Text] [Related]

  • 14. Modelling cortical cataractogenesis VII: Effects of vitamin E treatment on galactose-induced cataracts.
    Creighton MO, Ross WM, Stewart-DeHaan PJ, Sanwal M, Trevithick JR.
    Exp Eye Res; 1985 Feb; 40(2):213-22. PubMed ID: 3979462
    [Abstract] [Full Text] [Related]

  • 15. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
    Beyer-Mears A, Cruz E, Nicolas-Alexandre J, Varagiannis E.
    Pharmacology; 1982 Feb; 24(3):193-200. PubMed ID: 6803262
    [Abstract] [Full Text] [Related]

  • 16. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG, Stevens MJ.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS, Kim J, Lee YM, Sohn E, Jo K, Kim JS.
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [Abstract] [Full Text] [Related]

  • 18. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J, Kim CS, Sohn E, Lee YM, Kim JS.
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V, Kumar PA, Naik RR, Sridhar G, Kumar MP, Gopal VV, Raju TN.
    J Ethnopharmacol; 2013 Aug 26; 149(1):215-21. PubMed ID: 23827758
    [Abstract] [Full Text] [Related]

  • 20. Modelling cortical cataractogenesis: VI. Induction by glucose in vitro or in diabetic rats: prevention and reversal by glutathione.
    Ross WM, Creighton MO, Trevithick JR, Stewart-DeHaan PJ, Sanwal M.
    Exp Eye Res; 1983 Dec 26; 37(6):559-73. PubMed ID: 6662206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.